1 suspended. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Suspended 1 |
Follow Histiocytic Sarcoma: new trials by email Literature Review of Histiocytic Sarcoma trials Research Report on Histiocytic Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab in Neoplasms or Lymphomas Pembrolizumab - Lymphoma, Histiocytic Sarcoma | Phase 2 | Suspended | Dana-Farber Cancer Institute | 18 | 2017-12-07 | 2026-08-06 |
Dendritic Cell Sarcoma, Follicular (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Lymphoma (1)
Hemic and Lymphatic Diseases (1) · Histiocytic Disorders, Malignant (1) · Histiocytosis (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
pembrolizumab (1)
Dana-Farber Cancer Institute (1)
United States (1)